0.00Open0.05Pre Close0 Volume100 Open Interest7.50Strike Price0.00Turnover429.36%IV499.21%PremiumSep 20, 2024Expiry Date0.00Intrinsic Value100Multiplier21DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.1141Delta0.1474Gamma25.20Leverage Ratio-0.0059Theta0.0001Rho2.87Eff Leverage0.0006Vega
Adaptimmune Therapeutics Stock Discussion
after the product is approved, profitable, it's your time to shine.
$Adaptimmune Therapeutics (ADAP.US)$
come on
😩. I wish I had more capital. This is about to run hard.
Turnaround proxy after FDA approval.
The treatment or cure of cancer, will be a huge business.
$Adaptimmune Therapeutics (ADAP.US)$
No comment yet